PrecisionMed
Generated 5/9/2026
Executive Summary
PrecisionMed is a specialized biospecimen provider and biorepository serving biomedical research, with a focus on neuroscience and oncology. Founded in 1996 and headquartered in San Diego, the company supplies immediately available, well-annotated human biological samples—including cerebral spinal fluid (CSF), serum, plasma, and tissue—paired with detailed clinical data. As a subsidiary of BioIVT, PrecisionMed leverages an extensive network of clinical sites to collect longitudinal samples, supporting translational research and biomarker discovery. The company's long-standing presence and niche focus on high-quality biospecimens make it a reliable partner for academic and pharmaceutical researchers. However, as a private subsidiary, its growth trajectory is closely tied to BioIVT's strategic priorities, and it lacks independent financial disclosures or publicly traded catalysts.
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)